Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.
Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.
Antibiotics, discovered in the early twentieth century, came into widespread use after the Second World War, with substantial public health benefits. Antibiotic use has increased markedly, now approximating one antibiotic course per year in the average child in the United States 1,2 . However, there is increasing concern that antibiotic exposure may have long-term consequences [3] [4] [5] . For more than 50 years we have known that the administration of low doses of antibacterial agents promotes the growth of farm animals, consequently, in the United States, the largest use of antibiotics and related antimicrobial substances is within farms, with low doses fed to large numbers of animals used for food production to increase weight gain by as much as 15% 6, 7 . These effects are broad across vertebrate species, including mammals (cattle, swine, sheep) and birds (chickens, turkeys), and follow oral administration of the agents, either in feed or water, indicating that the microbiota of the gastrointestinal (GI) tract is a major target. That the effects are observed with many different classes of antibacterial agents (including macrolides, tetracyclines, penicillins and ionophores) indicates that the activity is not an agent-specific side effect, nor have the effects been observed with antifungals or antivirals.
The vertebrate GI tract contains an exceptionally complex and dense microbial environment, with bacterial constituents that affect the immune responses of populations of reactive host cells 8 and stimulate a rich matrix of effecter mechanisms involved in innate and adaptive immune responses 9 . The GI tract also is a locus of hormone production, including those involved in energy homeostasis (such as insulin, glucagon, leptin and ghrelin) and growth (for example, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1)) 10 . Alterations in the populations of the GI microbiota may change the intra-community metabolic interactions 11 , modify caloric intake by using carbohydrates such as cellulose that are otherwise indigestible by the host 12 , and globally affect host metabolic, hormonal and immune homeostasis 13 . Full (therapeutic) dose antibiotic treatments alter both the composition of the gastrointestinal microbiota 14 and host responses to specific microbial signals 15 . In combination with dietary changes, antibiotic administration has been associated with changes in the population structure of the microbiome. However, the effects of exposure to subtherapeutic antibiotic dosages have not been described.
Early studies of the effects of gut microbiota on metabolism were limited by the use of culture-based technologies that interrogated ,5% of the extant GI tract microbes 16 . Culture-independent investigation of small-subunit ribosomal RNA sequences allows the microbial population structure 17 of the gut microbiota to be characterized with greater resolution. Despite inter-individual differences, substantial similarities exist 18 among mammalian species in the GI microbiota at higher taxonomic levels and functional pathways, indicating a basis for the conserved responses to early-life subtherapeutic antibiotic treatment (STAT) within farms. Previous work has shown that obesity leads to variation in the GI microbiome 12, 19 ; we use the insights provided from modern agricultural practices to suggest an alternative approach, using a murine model of STAT to explore how antibiotic exposure modulates host metabolic phenotypes. (Fig. 1e) . Thus, 7 weeks after starting the intervention, each of several STAT exposures changed body composition but not overall weight. Repeat STAT experiments showed similar results ( Supplementary  Fig. 2 ). There were no significant differences in calculated feed efficiency, expressed as weight gained per unit of feed consumed, between the STAT and control mice. In a larger, confirmatory experiment to assess when the morphometric changes appear, we began examining the mice immediately at weaning. Both the STAT males and females showed significantly increased early life growth rates ( Supplementary  Fig. 3A) , and fat mass in the STAT animals began to diverge from controls by 16-20 weeks, in both males and females. Between 8 and 26 weeks, there were significantly increased rates of fat accumulation in both female and male STAT mice (0.042 and 0.045 g week 21 , respectively) compared to controls; female mice also showed significantly increased total mass ( Supplementary Fig. 3B ). These studies confirm the increased adiposity associated with STAT in females, show parallel effects in males, and indicate that the morphometric changes begin at the earliest time (day 22) of measurement.
Bone mineral density is increased in early-life growth
Bone mineral density (BMD) was evaluated by DEXA scanning in the control and STAT mice after 3 and 7 weeks of exposure. At 3 weeks, the BMDs in each of the five STAT groups (and overall) was significantly increased compared to controls (Fig. 2a) . By 7 weeks, the BMDs in all mice increased, without significant differences between the STAT (0.045 6 0.002 mg cm
22
) and control mice (0.046 6 0.003 mg cm 22 ) (Fig. 2a) . Thus, an early bone developmental phenotype observed in each of the STAT groups normalized by 7 weeks. Parallel observations have been made in other STAT experiments (data not shown).
Increased GIP in STAT mice
To examine metabolic correlates to the changes in body composition, we assessed GIP, an incretin synthesized by small intestinal K cells 20 with receptors located on adipocytes that stimulates lipoprotein lipase activity 21 . GIP was significantly elevated in the STAT mice (39.1 6 2.5 pg ml
21
) compared to controls (24.4 6 4.2 pg ml 21 ), with the levels ranging from 34.3 6 6.1 pg ml 21 in the penicillin group to 44.9 6 3.7 pg ml 21 in the chlortetracycline group (Fig. 2b) . Increases in GIP levels are consistent with existing mouse models of obesity, such as in IRS-1/GIPR and Kir6.2/GIPR double knockout mice that show increased levels of GIP, adiposity and serum glucose 22, 23 . GIP elevation in STAT mice provides a mechanism for the observed adiposity increase 24, 25 , but also could be secondary to the metabolic changes. There were no significant differences for fasting insulin-like growth factor (IGF)-I, insulin, peptide YY, leptin, or ghrelin levels between control and STAT mice ( Supplementary Fig. 4 ). Glucose tolerance tests performed during week 6 of the experiment showed a trend towards hyperglycaemia in STAT mice ( Supplementary Fig. 5 ).
STAT does not alter overall gut microbial census
To determine whether the STAT exposure leading to these metabolic changes affected the GI tract microbiome, microbial DNA extracted from faecal and caecal samples collected from the mice during the week of euthanasia or at necropsy, respectively, were studied. DNA concentrations measured from both caecal (77.62 6 33.51 ng ml 21 ) and faecal (23.79 6 14.41 ng ml 21 ) samples were not significantly different between control (n 5 10) and STAT mice (n 5 10 per group). The census in the STAT and control mice, determined through quantitative PCR using 338F/518R universal primers (Supplementary Table 1 ), showed no significant differences in bacterial counts or fungal census among the STAT and control groups (Fig. 3a) . These data indicated that STAT exposure did not lead to substantial changes in the overall microbial census, and next led to us to conduct an assessment of the composition of the populations.
STAT alters the composition of intestinal microbiota
To assess microbial populations in the STAT and control microbiomes, we analysed the relative distribution of taxonomic groups based on 16S rRNA v3 region sequence data. The extracted DNA was subjected to 454 pyrosequencing, yielding 555,233 readable sequences (5,784 6 676 sequences per sample with mean length 188 6 3 bp). The sequences were analysed at multiple (phylum to genus) taxonomic levels ( Supplementary Fig. 6 and Supplementary Table 2 ). In both faecal and caecal samples, the ratio of Firmicutes to Bacteria was significantly elevated in the STAT mice compared to controls ( Fig. 3b and Supplementary Fig. 7 ). Weighted Unifrac analysis of the dominant taxa (present in .1% of the total population) showed a nonrandom clustering of STAT and control mice (P , 0.05) (Fig. 3c) . Importantly, deep branching was identified, with the mean weight of mice on the two major branch points on the heat map being 3 weeks of STAT, bone mineral density was significantly increased in each group (n 5 10 mice per group) compared to controls (*P , 0.05) but did not persist at 7 weeks. b, Serum GIP levels measured at death were significantly increased in the vancomycin, penicillin plus vancomycin, and chlortetracycline groups and in the aggregate antibiotic group compared to controls (P , 0.05). Data are presented as mean 6 s.e.m. Box plots show median 6 interquartile range (IQR) and 95% ranges (whiskers). pdf) demonstrated consistent shifts within the microbial populations in the STAT-exposed groups. Although STAT did not change the overall bacterial census, even the minimal antibiotic doses caused shifts in taxonomic composition, such as the Lachnospiraceae bloom. We noted an increase in the relative concentrations of Firmicutes compared to Bacteroidetes in the STAT mice compared to controls, which accompanied the observed increases in adiposity. This observation extends previous findings 26, 27 of relative increases in the Firmicute population in ob/ob mice that are genetically prone to obesity. However, observations at such high taxonomic strata may not sufficiently describe the changes associated with obesity 28, 29 ; variations in DNA extraction efficiency and PCR-based sequencing of complex, heterogeneous microbial communities may bias census estimates of specific bacterial taxa. Furthermore, although the overall phenotypes (increased adiposity and hepatic lipogenesis) are consistent in the STAT groups, the intermediate steps may be more host-and treatment-specific. Our findings indicate that specific STAT exposures can be used as probes of microbiome structure and function.
STAT exposure alters gut microbiome SCFA metabolism
Because of the central role of short-chain fatty acid (SCFA) synthesis in colonic metabolism 30, 31 , we examined the effect of STAT exposure on the gene counts of prokaryotic genes butyryl coA transferase (BCoAT) and formyltetrahydrofolate synthetase (FTHFS) that are involved in butyrate and acetate synthesis, respectively (Supplementary Fig. 12 ). Quantitative PCRs (qPCRs) for total bacteria, and degenerate qPCRs for BCoAT and FTHFS, were performed on caecal specimens in control and STAT mice. At 3 weeks, there were significant decreases in BCoAT gene copy numbers in the penicillin plus vancomycin, chlortetracycline, and aggregate groups. By 6 weeks, BCoAT copy numbers had increased in all the groups compared to the 3-week values, but there was no longer an aggregate difference. For FTHFS overall, there were no significant differences between control and STAT mice overall at 3 or 6 weeks, although there was variation within the antibiotic groups (Fig. 4a) . Exploring the inter-antibiotic differences further, we noted that there were several patterns in the FTHFS qPCR with different melting curve peaks ( Supplementary  Fig. 13 ), indicating differences in the microbial population. In total, these results provide evidence that STAT treatment is dynamically affecting composition of genes related to SCFAs, probably in antibiotic-specific ways, but with overall conserved effects. Both BCoAT and FTHFS have a role in metabolism of carbohydrates into SCFAs 32 and have been used to assess the functional characteristics of complex communities 33 ; the observed changes in gene copy numbers in young STAT mice relative to controls as well as changes at different time points provide evidence that the STAT colonic microbiome alters SCFA metabolism. Our finding that the copy numbers of these C4  VP8  C5  T4  V8  P9  P8  VP4  T7  VP10  T10  VP9  T1  V6  T8  T3  T2  P6  V7  P10  P3  VP2  VP7  VP3  T6  T9  C7  C2  C1  C3  V10  V1  V5  C10  V2  P1  C8  V3  C9  VP1  V9  V4  P2  P4 a, There were no significant differences in microbial census between the STAT and control groups (n 5 10 mice per group) evaluated by qPCR with universal primers for 16S rRNA and internal transcribed spacer (ITS). b, By 454-pyrosequencing, Firmicutes were shown to be increased in the STAT mice at multiple taxonomic levels. (Controls n 5 10, penicillin n 5 9, vancomycin n 5 10, penicillin plus vancomycin n 5 8, chlortetracycline n 5 10; *P , 0.05.) Data are presented as mean 6 s.e.m. c, Heat map of specimens showing relative abundance of bacteria present at .1% at the family taxonomic level. Hierarchical clustering based on Euclidean distance identified nonrandom branch distributions of control and STAT mice (P , 0.05). Lachno., Lachnospiraceae; Porphyr., Porphyromonadaceae.
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two genes increase during growth (between 3 and 6 weeks) in both control and STAT mice (Fig. 4) suggests a greater dependence on SCFA synthesis pathways with maturation. Relative differences in the extent of these changes and in the melting curve peak populations may reflect changes in microbial populations. Furthermore, gene copy number (Fig. 4 ) in conjunction with melting curve peak patterns ( Supplementary Fig. 13 ) may be useful for studying community genotypes of metabolic potential. Direct measurements of SCFAs in the caecal contents of control and STAT mice demonstrate substantial increases in acetate, propionate and butyrate in all STAT groups (Fig. 4b) ; ratios of butyrate to acetate are also significantly altered by STAT exposure (Fig. 4c) . These findings provide evidence that STAT exposure perturbs not only the composition of the GI microbiome but also the metabolic capabilities of the microbiome, specifically with respect to SCFAs. Increased SCFA concentrations and butyrate/acetate levels provide mechanisms for the STAT-induced adiposity phenotypes. SCFAs directly provide energy to colonocytes, and absorption into the portal circulation stimulates adipogenesis 30, 34 . Metabolic cage experiments examining metabolic balance show no significant difference in caloric intake between control and STAT mice but lower caloric output in faecal pellets from STAT mice (Supplementary Fig. 14) , providing evidence for selection for microbiota that can extract calories from otherwise indigestible constituents.
STAT alters hepatic metabolism of fatty acids and lipids
In confirmatory experiments using the identical STAT penicillin protocol, liver tissue was collected from both control and STAT mice. Standard histological analysis and triglyceride measurements showed no significant differences between control and STAT mice ( Supplementary Fig. 15a, b ). There were no significant differences in 16S rRNA gene counts, as detected by qPCR, from the liver specimens, providing evidence that bacterial translocation is not altered in the STAT mice (Supplementary Fig. 15c ). Microarray analyses surveyed for differences in .45,000 genes, identifying 466 that by t-test or post translational modification statistics (PTM) were significantly up-or downregulated (397 significantly differed from controls by both tests) in the STAT compared to control mice. Focusing on pathways related to fatty acid metabolism and lipid metabolic processes, 22 and 47 genes, respectively, were differentially expressed between STAT and control mice (Fig. 5a ). When specific genes were mapped to murine hepatic metabolic pathways, there were consistent changes in the same direction for several pathways, including upregulation in pathways related to lipogenesis and triglyceride synthesis (Fig. 5b) . The changes in gene expression observed by microarray analyses were extended by qPCR assays of the same genes ( Supplementary Fig. 16 ). These microarray and qPCR findings demonstrate substantial changes in the regulation of hepatic lipid, cholesterol and triglyceride metabolism that result from STAT-induced intraluminal intestinal changes.
Increased STAT adiposity is not metabolically altered
In the same confirmatory experiments (Supplementary Fig. 3 ), visceral adipose tissue dissected from control and STAT (penicillin) mice had no significant differences in adipocyte counts (Supplementary Fig. 17a, c) or in immunohistochemical staining for CD68 1 macrophages ( Supplementary Fig. 17b, d ). These findings were extended by Gapdh-normalized ( Supplementary Fig. 17e ) metabolic gene qPCR analyses. There were no significant differences in leptin, adiponectin, resistin, sterol regulatory element binding transcription factor 1 (Srebf1, also called SREBP1c), peroxisome proliferator activated receptor c (Pparg, also called PPARc2), and fatty acid synthase (Fasn, also called FAS) levels between the control and STAT groups ( Supplementary  Fig. 17f ). These findings provide evidence that STAT adipose tissue shows no substantial physiological difference compared to controls in cell density, local inflammation, or metabolic potential as demonstrated by quantitative PCR. Increased adiposity seems to be a downstream phenomenon primarily mediated by changes in the gut and liver.
Discussion
By developing a model to assess adiposity, we show that each of the several STAT approaches tested affects the adiposity of post-weaning C57BL/6J mice. Similarly, there was a consistent early change in bone development. Particularly in the dynamic phases of growth in young animals, STAT alterations of the microbiome may affect pluripotent cells that can become osteoblasts, adipocytes, or myocytes. Although the STAT model does not precisely replicate the weight gain observed in farm animals, possibly due to differences in the husbandry of laboratory mice in a clean environment versus animals raised on a farm, the broad effects of exposure demonstrated in this model provide evidence that altering the microbiome may have substantial consequences. Such changes in early-life body composition may be due to altered host responses 35, 36 and/or shifts in the metabolic characteristics of the gut microbiome. We postulate that the STAT exposures selected for microbiota with increased metabolic activity that were able to extract a higher proportion of calories from dietary complex carbohydrates that were relatively indigestible in the control mice. The increased SCFA concentrations are the metabolic products of this activity, which then may be delivered in increased quantities through the portal circulation to the liver, enabling enhanced lipogenesis (Supplementary Fig. 18 ). Enhanced caloric absorption has been implicated as a mechanism for increased weight gain in other murine obesity models 12 . The observed increase in PCR was performed for butyryl CoA transferase (BCoAT) and formyltetrahydrofolate synthetase (FTHFS) at experiment weeks 3 and 6 on STAT and control groups (n 5 10 mice per group). At 3 weeks, BCoAT was diminished in two STAT groups and the aggregate group, a difference that persisted only in the chlortetracycline group. FTHFS copies do not show a consistent pattern. *P , 0.05, **P , 0.01, ***P , 0.001 comparing STAT to controls; hash symbol indicates significant difference between 3 and 6 weeks. b, SCFA concentration analysed by gas chromatography (GC) shows increases in SCFAs in each of the STAT groups compared to controls. c, The ratio of butyrate relative to acetate is significantly higher in the STAT mice than controls. Data are presented as mean 6 s.e.m.
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adiposity is similar across several different STAT exposures, despite the different antibiotics used. This is consistent with the observation that a wide range of FDA-approved antibacterial agents are used for effective growth promotion in the agricultural industry 6, 7, 37 . Our studies of the intestine, liver and adipose tissue demonstrate that the active effect of the antibiotics is on the microbiota affecting the downstream liver; mechanistically, the adipose tissue is passively accepting the increased lipid load produced from more proximal activities.
Why might STAT exposures have such substantial effects on recipient animals? We propose that STAT represents a compounded perturbation, as described previously 38 , that has more serious consequences for long-term alterations of community state, possibly generating a different assemblage of species. The STAT-induced increase in SCFA production is a change in substrate availability that is a characteristic 39 of ecological disturbance. Such overharvesting, at a developmentally sensitive time, may push the ecosystem beyond the normative recovery that usually follows infrequent disturbances 38 . In complex, co-evolved ecosystems, the intricate interactions among participants conform to equilibria 40 that promote the robustness of a community 41 . However, when such equilibria are substantially perturbed, changes in host health and disease may result 42 . Other causative mechanisms for the changes in host phenotype could reflect that maturation of the gut microbiome is temporally altered by STAT exposure or that host responses are altered by microbiome changes. Ultimately, the interaction between the microbiome's metabolic capabilities and numerous host reactive cells could account for the observed changes, including the increase in GIP. In our study, we confirm in a tractable experimental model the decades-long observations in farm animals that STAT exposure changes host development, and we demonstrate specific techniques useful for studying the metabolic effects of microbiome manipulation. Our study also indicates the possibility that modulation of the infant human gut microbiome by antibiotics could have long-term metabolic consequences affecting adiposity and bone development.
METHODS SUMMARY
Female C57BL/6J mice were given penicillin, vancomycin, penicillin plus vancomycin, or chlortetracycline (1 mg antibiotic per g body weight) via drinking water, or no antibiotics (control). Body weight was serially measured and body composition determined using dual energy X-ray absorptiometry (DEXA). At death, blood, caecal contents, liver and visceral adipose tissue were collected, and serum hormones measured. DNA was extracted from caecal contents and faecal pellets, and 16S rRNA gene v3 regions were barcoded and sequenced, using 454-FLX Titanium chemistry. Quality-filtered sequences were processed through the QIIME pipeline and analysed in the R statistical environment. Quantitative PCR assessed taxa and metabolic genes of interest, and expression profiling of hepatic RNA was performed by microarray.
Full Methods and any associated references are available in the online version of the paper. Control STAT a   ALDH3A2  DCI  EHHADH  ACAT1  PECI  ACSL1  HADH  HADHB  ACADL  ACOX1  ACADM  CPT2  ADH5  CPT1B  HADHA  ACAA2  GCDH  ACSL5  ACSL6  ACADVL  ACAT2  ECHS1  PPARG  THRSP  ALDH3A2  ACOT2  RETSAT  SREBF1  ACOT1  CIDEA  CHPT1  PLA2G6  CD74  WWOX  MGLL  ECH1  SERINC2  ADIPOR2  NR2F2  PIGH  NPC1  PIGC  CYP46A1  HPGD  ALOX12B  FADS2  PLA2G2D  AGPAT6  PECI  SHH  NR1I2  MGST3  HADHB  PLTP  ACOT4  ACOX1  ACOT9  OXSM  PDSS2  BDH2  PIK3R1  ABCD2  ALDH5A1  AGPAT2  ST8SIA5  PIGV  NR1H4 identified through microarray and quantitative PCR analyses. a, Microarray analysis of liver specimens surveyed for differences in .45,000 genes; 397 genes were significantly up-or downregulated. Heat maps generated by gene set enrichment analysis (GSEA) 43 identify differences between the STAT and control mice (n 5 6 mice per group), including pathways related to fatty acid metabolism and lipid metabolic processes. b, Mapping of metabolic genes detected by microarray onto specific pathways, including those related to lipogenesis and triglyceride synthesis, show consistent changes with STAT. Data are presented as mean 6 s.e.m. White bars, controls; black bars, STAT; *P , 0.05, **P , 0.01. TG, triglycerides; VLDL, very low-density lipoproteins.
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METHODS
Mouse husbandry. Female C57BL/6J mice were obtained at weaning (21 days of life) from Jackson Laboratories and allowed to adjust to the NYU animal facility for 1 week. Mice were weighed at the beginning of each experiment and distributed five per cage so that mean weights in each cage were equal. In each experiment, each study group (control or antibiotic(s)) was composed of ten mice. The mice were allowed ad libitum access to food and water and were maintained on a 12-h light/dark cycle and fed standard laboratory chow (Purina Mills International Diet no. 5001). The protocol was approved by the New York University School of Medicine Institutional Animal Care and Use Committee (IACUC). Antibiotic dosing. Beginning on day 28 of life, mice were given standard water (pH 6.8) or water containing one of the following antibiotic regimens: penicillin VK, vancomycin, penicillin VK plus vancomycin, and chlortetracycline. Doses were adapted from the FDA Green Book and generally were in the mid-range of those approved for use in agriculture 6, 7, 37 . To simplify administration, the antibiotics were added to drinking water at a dose of 1 mg antibiotic per g body weight of the mice in the cage, based on the calculation that daily water intake is proportional to body weight. In previous studies, the daily water intake in C57BL/ 6J mice averaged 15 ml water per 100 g body weight 44 . Water containers were changed twice weekly to supply fresh antibiotics. Mouse measurements and phenotypes. Three times a week, each mouse was weighed twice on an electronic scale tared between all measurements. The quantity of feed consumed per cage was measured and average daily feed intake calculated. Feed efficiency was calculated by dividing mean weight gain by mean daily feed consumed per mouse. Faecal pellets were collected every week and stored at 220 uC until processing. Body composition was determined using dual energy X-ray absorptiometry (DEXA) with a Lunar PIXImus II mouse densitometer (GE Medical Systems) at weeks 3 and 7. Each mouse was scanned individually and data collected on fat composition, lean body mass, per cent body fat, and bone mineral density. MRI experiments were performed on a 7 tesla MRI system gated on respiratory rate. During the scan, anaesthesia was maintained with 1.5% isoflurane in oxygen. The animal body temperature was maintained at 37 uC (61 uC) during the scan by directing a thermostatically controlled warm air source. Images captured were separated into fat and lean tissue using the IDEAL Dixon method based on chemical shift properties 45 and total body fat percentage (volume/ volume) was calculated by merging fat and lean images in MRIcron software (http://www.mccauslandcenter.sc.edu/mricro/mricron/). Weight values were validated by comparisons with scale weight and fat% values with MRI-determined fat% ( Supplementary Fig. 1 ). Mice were killed by CO 2 inhalation and cervical dislocation and blood was collected via cardiac puncture. The blood was separated into serum and whole cells. Necropsy was performed on each mouse and caecal contents, liver, serum and visceral adipose tissue were collected. All samples were snap-frozen and stored at 280 uC until processing. Statistical comparison of growth rates. From the experiment shown in Supplementary Fig. 4 , the plots of group means of total, fat and lean mass over time were fitted with the following linear spline model with a common knot at week 26: 2; SAS Institute, Inc.) were used to perform the tests and calculate the estimates. Hormone measurements. Blood cells and serum were separated through centrifugation (3,000g for 10 min at 4 uC) and the serum frozen at 270 uC. Serum specimens (100 ml) were examined using the Millipore Mouse Gut Hormone Panel (Millipore Corp.) using a Luminex 200 (Millipore) analyser. The panel was custom-designed to assess for glucose-dependent insulinotropic peptide (GIP), insulin, IGF-1, peptide YY, ghrelin and leptin. Glucose tolerance test. Control and STAT mice were fasted for 12 h during study week 6 (week 10 of life) and weights determined by electronic scale. Blood glucose at baseline was measured using an Accu-Chek Compact Plus glucometer (Roche). The mice then were challenged with 2 mg glucose per g body weight, given intraperitoneally, as previously described 46 , and blood glucose levels determined 30, 60 and 120 min later. Area under curve (AUC) calculations were used to compare the STAT and control groups between 30 and 60 min. DNA extraction. DNA extractions from caecal contents and faecal pellets were performed using the Qiagen QIAmp DNA stool extraction kit (Qiagen) per the manufacturer's protocol. Total extracted DNA was quantified using a Nanodrop 1000 (Thermo Scientific). PCR to confirm bacterial DNA extractions was performed using the 8F/1510R bacterial primers for 16S rRNA 47, 48 . Quantitative PCR amplification. After genomic DNA extraction and quantification, samples were prepared for amplification and sequencing at the JCVI Joint Technology Center (JTC). Genomic DNA sample concentrations were normalized to ,5-10 ng ml
21
. The v3 region of the 16S rRNA gene was amplified using forward primer 341F (59-CCTACGGGAGGCAGCAG-39) and reverse primer 534R (59-ATTACCGCGGCTGCTGG-39) to which a 'CG' on the 59 end of the primer followed by symmetrical 10-nucleotide barcodes were included as part of the primer design (59-CGN(10)116S primer-39). Barcoded primer designs were completed using a set of algorithms developed at the JCVI. This design allowed for the inclusion of a unique barcode to each sample at the time of PCR so that the tagged samples could be multiplexed for sequencing. A total of 96 barcodes were used. Every effort was made to prevent contamination of PCR reactions with exogenous DNA including a set of reactions in a laminar flow hood. PCR reactions were completed as follows (per reaction): 1 ml of gDNA, 13 final concentration of Accuprime PCR Buffer II (Invitrogen), 250 mM betaine, 200 nM forward and reverse primers, 0.5 units of Accuprime Taq DNA Polymerase High Fidelity (Invitrogen), and nuclease-free water to bring the final volume to 10 ml. PCR cycling conditions were: initial denaturation of 2 min at 95 uC followed by 25 cycles of 10 s at 95 uC, 20 s at 63 uC and 30 s at 72 uC. A negative control (water blank) reaction also was included and examined after 30 cycles. PCR reactions were visualized on 1% agarose gels and quantified using a Tecan SpectraFluor Plus (Tecan Group Ltd) before normalization and pooling of samples for sequencing. 454-FLX read quality filtering. After the completion of sequencing, a read processing pipeline involving a set of modular scripts designed at the JCVI was used for deconvolution, trimming and quality filtering 49 . First reads were deconvoluted, or assigned to samples, based on their unique 10-nucleotide barcode, allowing #1-nucleotide mismatch to the reference barcode sequence and #6 primer sequence mismatches, using the EMBOSS program fuzznuc to locate barcodes and primer sequences on each read. To eliminate spurious hits, the distance between detected barcode and primer were required to be #3 nucleotides. Barcodes then were trimmed from the sequence and remaining sequences which failed to have barcodes detected then were filtered. After deconvolution, primer sequences detected at .75% identity were trimmed and those without valid primers detected were eliminated. Reads with an average length of ,100 nucleotides or with any Ns were removed. A BLASTN quality check 50 was performed against a small internal data set of 200 16S reads to remove sample reads substantially inconsistent with 16S gene sequences. The criteria were that .30% of the query must be covered by the alignment with a minimum of 60 nucleotides of identity. Passing reads were subsequently examined using a modified version of the RDP Chimera Check in which candidate chimaeras were identified based only on reads that were sequenced within the sample. Final sequence data have been deposited in the NIH Sequence Read Archive (http:// www.ncbi.nlm.nih.gov/sra). Accession numbers for all primary sequencing data are available from the NCBI under BioProject 168618. Sequence analyses. The pooled sample was cleaned using the Agencourt AMPure system (Beckman Coulter Genomics). The A and B adapters necessary for sequencing with 454-FLX Titanium chemistry (Roche) were subsequently ligated to the sample pool after PCR following standard manufacturer protocols. Library construction, emPCR, enrichment, and 454 sequencing were performed by following the vendor's standard operating procedures with some modifications. Specifically, quantitative PCR was used to accurately estimate the number of molecules needed for emPCR. We also used automation (BioMek FX) to 'break' the emulsions after emPCR and we used butanol to enable easier sample handling during the breaking process. Statistical and computational sequence analysis. Quality-filtered sequences (see Supplementary Methods) were pre-processed through the QIIME pipeline 51 involving: (1) clustering the sequences into operational taxonomical units (OTUs) using the UCLUST program 52 at a 97% similarity threshold; (2) taxonomically assigning each OTU by selecting a representative sequence from each OTU-cluster and running RDP Classifier 53 with 80% bootstrap confidence; (3) aligning representative sequences for each OTU with the Greengenes core-set alignment template using PyNAST 54 ; (4) building a phylogenetic tree for the OTUs using the FASTTREE program 55 ; and (5) calculating weighted Unifrac beta-diversity indices 56 . We extracted the OTU absolute abundance table and weighted Unifrac beta-diversity matrix 56, 57 from the pipeline for further analysis in the R statistical programming environment 58, 59 . The rarefactions for diversity indices and species richness were calculated in the R statistical programming environment 59 ,60 using Community Ecology Package Vegan. The OTU absolute abundances were converted to relative abundances by normalizing to total ARTICLE RESEARCH
